Literature DB >> 18347055

Lys63-linked polyubiquitination of IRAK-1 is required for interleukin-1 receptor- and toll-like receptor-mediated NF-kappaB activation.

Dietrich B Conze1, Chuan-Jin Wu, James A Thomas, Allison Landstrom, Jonathan D Ashwell.   

Abstract

Stimulation through the interleukin-1 receptor (IL-1R) and some Toll-like receptors (TLRs) induces ubiquitination of TRAF6 and IRAK-1, signaling components required for NF-kappaB and mitogen-activated protein kinase activation. Here we show that although TRAF6 and IRAK-1 acquired Lys63 (K63)-linked polyubiquitin chains upon IL-1 stimulation, only ubiquitinated IRAK-1 bound NEMO, the regulatory subunit of IkappaB kinase (IKK). The sites of IRAK-1 ubiquitination were mapped to Lys134 and Lys180, and arginine substitution of these residues impaired IL-1R/TLR-mediated IRAK-1 ubiquitination, NEMO binding, and NF-kappaB activation. K63-linked ubiquitination of IRAK-1 required enzymatically active TRAF6, indicating that it is the physiologically relevant E3. Thus, K63-linked polyubiquitination of proximal signaling proteins is a common mechanism used by diverse innate immune receptors for recruiting IKK and activating NF-kappaB.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18347055      PMCID: PMC2423148          DOI: 10.1128/MCB.02098-07

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  55 in total

1.  MyD88 is an adaptor protein in the hToll/IL-1 receptor family signaling pathways.

Authors:  R Medzhitov; P Preston-Hurlburt; E Kopp; A Stadlen; C Chen; S Ghosh; C A Janeway
Journal:  Mol Cell       Date:  1998-08       Impact factor: 17.970

2.  MyD88, an adapter protein involved in interleukin-1 signaling.

Authors:  K Burns; F Martinon; C Esslinger; H Pahl; P Schneider; J L Bodmer; F Di Marco; L French; J Tschopp
Journal:  J Biol Chem       Date:  1998-05-15       Impact factor: 5.157

3.  Overexpression of an enzymically inactive interleukin-1-receptor-associated kinase activates nuclear factor-kappaB.

Authors:  B Maschera; K Ray; K Burns; F Volpe
Journal:  Biochem J       Date:  1999-04-15       Impact factor: 3.857

4.  MyD88: an adapter that recruits IRAK to the IL-1 receptor complex.

Authors:  H Wesche; W J Henzel; W Shillinglaw; S Li; Z Cao
Journal:  Immunity       Date:  1997-12       Impact factor: 31.745

5.  The interleukin-1 receptor-associated kinase is degraded by proteasomes following its phosphorylation.

Authors:  T T Yamin; D K Miller
Journal:  J Biol Chem       Date:  1997-08-22       Impact factor: 5.157

6.  Reprogramming the signalling requirement for AP-1 (activator protein-1) activation during differentiation of precursor CD4+ T-cells into effector Th1 and Th2 cells.

Authors:  M Rincón; B Dérijard; C W Chow; R J Davis; R A Flavell
Journal:  Genes Funct       Date:  1997-02

7.  TRAF6 is a signal transducer for interleukin-1.

Authors:  Z Cao; J Xiong; M Takeuchi; T Kurama; D V Goeddel
Journal:  Nature       Date:  1996-10-03       Impact factor: 49.962

8.  Dominant negative mutant of c-Jun inhibits NF-AT transcriptional activity and prevents IL-2 gene transcription.

Authors:  D Petrak; S A Memon; M J Birrer; J D Ashwell; C M Zacharchuk
Journal:  J Immunol       Date:  1994-09-01       Impact factor: 5.422

9.  IRAK: a kinase associated with the interleukin-1 receptor.

Authors:  Z Cao; W J Henzel; X Gao
Journal:  Science       Date:  1996-02-23       Impact factor: 47.728

10.  Interleukin (IL)-1 receptor-associated kinase (IRAK) requirement for optimal induction of multiple IL-1 signaling pathways and IL-6 production.

Authors:  P Kanakaraj; P H Schafer; D E Cavender; Y Wu; K Ngo; P F Grealish; S A Wadsworth; P A Peterson; J J Siekierka; C A Harris; W P Fung-Leung
Journal:  J Exp Med       Date:  1998-06-15       Impact factor: 14.307

View more
  108 in total

Review 1.  Emerging role of Lys-63 ubiquitination in protein kinase and phosphatase activation and cancer development.

Authors:  W-L Yang; X Zhang; H-K Lin
Journal:  Oncogene       Date:  2010-06-07       Impact factor: 9.867

Review 2.  Deciphering the complexity of Toll-like receptor signaling.

Authors:  Renato Ostuni; Ivan Zanoni; Francesca Granucci
Journal:  Cell Mol Life Sci       Date:  2010-07-31       Impact factor: 9.261

Review 3.  Signaling to NF-kappaB: regulation by ubiquitination.

Authors:  Ingrid E Wertz; Vishva M Dixit
Journal:  Cold Spring Harb Perspect Biol       Date:  2010-03       Impact factor: 10.005

Review 4.  "Without Ub I am nothing": NEMO as a multifunctional player in ubiquitin-mediated control of NF-kappaB activation.

Authors:  Jérémie Gautheron; Gilles Courtois
Journal:  Cell Mol Life Sci       Date:  2010-05-26       Impact factor: 9.261

Review 5.  NF-κB signaling pathways regulated by CARMA family of scaffold proteins.

Authors:  Marzenna Blonska; Xin Lin
Journal:  Cell Res       Date:  2010-12-28       Impact factor: 25.617

6.  The anti-inflammatory effect and potential mechanism of cardamonin in DSS-induced colitis.

Authors:  Gaiyan Ren; Aning Sun; Chao Deng; Jingjing Zhang; Xiaojun Wu; Xiaohui Wei; Sridhar Mani; Wei Dou; Zhengtao Wang
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2015-08-06       Impact factor: 4.052

Review 7.  CYLD: a tumor suppressor deubiquitinase regulating NF-kappaB activation and diverse biological processes.

Authors:  S-C Sun
Journal:  Cell Death Differ       Date:  2010-01       Impact factor: 15.828

Review 8.  Role of non-degradative ubiquitination in interleukin-1 and toll-like receptor signaling.

Authors:  Sinéad E Keating; Andrew G Bowie
Journal:  J Biol Chem       Date:  2008-08-06       Impact factor: 5.157

9.  Molecular mechanism underlying the suppression of lipid oxidation during endotoxemia.

Authors:  Urmila Maitra; Samantha Chang; Neeraj Singh; Liwu Li
Journal:  Mol Immunol       Date:  2009-09-20       Impact factor: 4.407

10.  The E3 ubiquitin ligase MARCH8 negatively regulates IL-1β-induced NF-κB activation by targeting the IL1RAP coreceptor for ubiquitination and degradation.

Authors:  Rui Chen; Mi Li; Yu Zhang; Qian Zhou; Hong-Bing Shu
Journal:  Proc Natl Acad Sci U S A       Date:  2012-08-16       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.